Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
The Indian government will float a global tender in April 2023 to procure HPV vaccines.
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
Filing for WHO Emergency Use Authorisation this month
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Biocon Biologics Limited will have access to 100 million doses of vaccines annually together with the distribution rights to Serum's Vaccine portfolio
Subscribe To Our Newsletter & Stay Updated
